157 related articles for article (PubMed ID: 25973483)
21. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies.
Muzaffar S; Shahid W; Riaz N; Saleem M; Ashraf M; Aziz-Ur-Rehman ; Bashir B; Kaleem A; Al-Rashida M; Baral B; Bhattarai K; Gross H
Bioorg Chem; 2021 Feb; 107():104525. PubMed ID: 33317840
[TBL] [Abstract][Full Text] [Related]
22. 15-Lipoxygenase inhibitory effects of prenylated flavonoids from Erythrina senegalensis.
Togola A; Hedding B; Theis A; Wangensteen H; Rise F; Smestad Paulsen B; Diallo D; Egil Malterud K
Planta Med; 2009 Aug; 75(10):1168-70. PubMed ID: 19288405
[TBL] [Abstract][Full Text] [Related]
23. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
24. [Lipophilic derivatives of caffeic acid as lipoxygenase inhibitors with antioxidant properties].
Mirzoeva OK; Sud'ina GF; Pushkareva MA; Korshunova GA; Sumbatian NV; Varfolomeev SD
Bioorg Khim; 1995 Feb; 21(2):143-51. PubMed ID: 7538294
[TBL] [Abstract][Full Text] [Related]
25. Inhibition mode of soybean lipoxygenase-1 by quercetin.
Ha TJ; Shimizu K; Ogura T; Kubo I
Chem Biodivers; 2010 Aug; 7(8):1893-903. PubMed ID: 20730955
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
[TBL] [Abstract][Full Text] [Related]
27. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
[TBL] [Abstract][Full Text] [Related]
28. N-Substituted pyrazole-3-carboxamides as inhibitors of human 15-lipoxygenase.
Pelcman B; Sanin A; Nilsson P; Schaal W; Olofsson K; Krog-Jensen C; Forsell P; Hallberg A; Larhed M; Boesen T; Kromann H; Claesson HE
Bioorg Med Chem Lett; 2015 Aug; 25(15):3017-23. PubMed ID: 26037319
[TBL] [Abstract][Full Text] [Related]
29. 3-Substituted pyrazoles and 4-substituted triazoles as inhibitors of human 15-lipoxygenase-1.
Pelcman B; Sanin A; Nilsson P; No K; Schaal W; Öhrman S; Krog-Jensen C; Forsell P; Hallberg A; Larhed M; Boesen T; Kromann H; Vogensen SB; Groth T; Claesson HE
Bioorg Med Chem Lett; 2015 Aug; 25(15):3024-9. PubMed ID: 26037322
[TBL] [Abstract][Full Text] [Related]
30. Novel lipoxygenase inhibitors, tetrapetalone B, C, and D from Streptomyces sp.
Komoda T; Kishi M; Abe N; Sugiyama Y; Hirota A
Biosci Biotechnol Biochem; 2004 Apr; 68(4):903-8. PubMed ID: 15118321
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and docking studies of 2,4,6-trihydroxy-3-geranylacetophenone analogs as potential lipoxygenase inhibitor.
Ng CH; Rullah K; Aluwi MF; Abas F; Lam KW; Ismail IS; Narayanaswamy R; Jamaludin F; Shaari K
Molecules; 2014 Aug; 19(8):11645-59. PubMed ID: 25100256
[TBL] [Abstract][Full Text] [Related]
32. Oleyl sulfate reveals allosteric inhibition of soybean lipoxygenase-1 and human 15-lipoxygenase.
Mogul R; Johansen E; Holman TR
Biochemistry; 2000 Apr; 39(16):4801-7. PubMed ID: 10769137
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, molecular properties, anti-inflammatory and anticancer activities of novel 3-hydroxyflavone derivatives.
Znati M; Bordes C; Forquet V; Lantéri P; Ben Jannet H; Bouajila J
Bioorg Chem; 2019 Aug; 89():103009. PubMed ID: 31158579
[TBL] [Abstract][Full Text] [Related]
34. The activity of flavonoids extracted from Tanacetum microphyllum DC. (Compositae) on soybean lipoxygenase and prostaglandin synthetase.
Abad MJ; Bermejo P; Villar A
Gen Pharmacol; 1995 Jul; 26(4):815-9. PubMed ID: 7635257
[TBL] [Abstract][Full Text] [Related]
35. Inhibition studies of soybean and human 15-lipoxygenases with long-chain alkenyl sulfate substrates.
Mogul R; Holman TR
Biochemistry; 2001 Apr; 40(14):4391-7. PubMed ID: 11284695
[TBL] [Abstract][Full Text] [Related]
36. Allylphenols as a new class of human 15-lipoxygenase-1 inhibitors.
Alavi SJ; Seyedi SM; Saberi S; Safdari H; Eshghi H; Sadeghian H
Drug Dev Res; 2021 Apr; 82(2):259-266. PubMed ID: 33022099
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of LOX by flavonoids: a structure-activity relationship study.
Ribeiro D; Freitas M; Tomé SM; Silva AM; Porto G; Cabrita EJ; Marques MM; Fernandes E
Eur J Med Chem; 2014 Jan; 72():137-45. PubMed ID: 24368208
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and SAR comparative studies of 2-allyl-4-methoxy-1-alkoxybenzenes as 15-lipoxygenase inhibitors.
Sadeghian H; Seyedi SM; Attaran N; Jabbari A; Jafari Z
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):238-44. PubMed ID: 20939767
[TBL] [Abstract][Full Text] [Related]
39. Flavonoid inhibition of soybean lipoxygenase.
Alcaraz MJ; Ferrándiz ML; Villar A
Pharmazie; 1986 Apr; 41(4):299-300. PubMed ID: 3088613
[No Abstract] [Full Text] [Related]
40. Quantitative structure-activity relationship of organosulphur compounds as soybean 15-lipoxygenase inhibitors using CoMFA and CoMSIA.
Caballero J; Fernández M; Coll D
Chem Biol Drug Des; 2010 Dec; 76(6):511-7. PubMed ID: 21040497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
